ISRCTN69287540CompletedNot Applicable
A randomised double-blind study to compare two regimens of Levonorgestrel in emergency contraception in Nigeria
World Health Organization (WHO) (Switzerland)0 sites3,150 target enrollmentStarted: April 1, 2004Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 3,150
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- Female
Inclusion Criteria
- •1. Requesting emergency contraception within 120 hours of unprotected intercourse
- •2. Only one act of unprotected intercourse during current cycle
- •3. Willing to abstain from further acts during current cycle
- •4. Regular menstrual cycles (24 to 42 days)
- •5. Having at least one spontaneous cycle before current cycle
- •6. Available for follow-up in the next six weeks
- •7. Negative pregnancy test
- •8. Willing to participate
- •9. Not breastfeeding
- •10. No use of hormonal contraceptives or of rhythm or natural family planning method of contraception during current cycle
- •11. Not unsure about the date of last menstrual period
Exclusion Criteria
- •Does not comply with the above inclusion criteria.
Investigators
Similar Trials
Completed
Not Applicable
A clinical trial to compare the pain sparing effects of dexamethasone and clonidine in patients undergoing shoulder surgery.CTRI/2017/02/007852Department of Anaesthesia and Intensive care60
Not yet recruiting
Unknown
Comparison of cervical epidural catheter directed up and down for breast surgeriesCTRI/2023/04/051908Esic medical college and hospital
Completed
Not Applicable
comparison of the effects of 2 lubricants (water based lubricant and betamethasone gel)used to lubricate the airway used for anesthesia (proseal LMA) on sore throat and hoarseness of voice after surgeryCTRI/2015/01/005435KASTURBA HOSPITAL KASTURBA MEDICAL COLLEGE MANIPA200
Active, not recruiting
Phase 1
A double blind comparative and randomised study in healthy adults of the safety, tolerability, and immunogenicity of PNEUMOVAX®II formulated with either all new process polysaccharides or all current process polysaccharidesPrevention of invasive pneumococcal disease (IPD)EUCTR2005-002789-12-GBSanofi Pasteur MSD S.N.C
Completed
Not Applicable
A Comparative study to decrease incidence of pain on injection of propofol using newer preparations of propofol emulsion.CTRI/2018/01/011562Vijayanagar Institute of Medical Sciences Ballari100